Your Health. Your Family. Your Choice.
Administered by: Other Purchased by: Other
Life Threatening? No
Write-up: This case was reported by a healthcare professional and described the occurrence of ileocolic intussusception in a 7-month-old male subject who was vaccinated with ROTARIX (GlaxoSmithKline). The subject was born at term, with birth weight 3.37 Kg. He had no personal or family history of intussusception. This case was collected through the Foreign Paediatric Surveillance Unit. Acute intussusception study occurring post rotavirus vaccination. Concurrent medical conditions included breast feeding. There were no change in the subject''s diet in the last week. The subject had no feeding intolerance of food sensitivities. Previous and/or concurrent vaccination included ROTARIX; GlaxoSmithKline; oral given on 6 May 2008. The subject didn''t receive any other vaccines during the last 2 weeks. He had no current treatment. On 7 July 2008, the subject received 2nd dose of ROTARIX (oral), lot number not provided. On 23 October 2008, 108 days after vaccination with ROTARIX, the subject was admitted to hospital due to ileocolic intussusception with intestinal mass, bile stained vomiting, pallor, lethargy, irritability and blood on rectal examination. The symptoms started less than 12 hours prior to diagnosis. The subject was hospitalised for 3 days. At examination, the body temperature was 37.2 Deg C. The abdomen X-ray revealed fluid level and dilated loops. The ultrasound showed non specific bowel gas. The diagnosis of intussusception was made based on abdomen ultrasound. Surgery was performed with an intestine resection. On 25 October 2008, a stool sample was collected and the subject was discharged alive. The results remained unknown. At the time of reporting the events were resolved.
Copyright © 2018 National Vaccine Information Center. All rights reserved.
21525 Ridgetop Circle, Suite 100, Sterling, VA 20166